Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0149-2027

Generic Name: FilmArray Pneumonia Panel plus Generic Name: FilmArray Pneumonia Panel plus Recall

Generic Name: FilmArray¿ Pneumonia Panel plus Generic Name: FilmArray¿ Pneumonia Panel plus Model/Catalog Number: RFIT-ASY-0143 (30 Kit), RFIT-ASY-0142 (6 Kit) Software Version: N/A Product Description: Multiple-type respiratory pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) Component: N/A

FDA recall Class II

Ongoing

FDA lists this Class II recall for Generic Name: FilmArray Pneumonia Panel plus Generic Name: FilmArray Pneumonia Panel plus. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0149-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 12, 2026
FDA report date
Oct 21, 2026
Quantity in commerce
3,871
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Generic Name: FilmArray Pneumonia Panel plus Generic Name: FilmArray Pneumonia Panel plus Model/Catalog Number: RFIT-ASY-0143 (30 Kit), RFIT-ASY-0142 (6 Kit) Software Version: N/A Product Description: Multiple-type respiratory pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) Component: N/A

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

Lot Code: UDI Nos 00815381020314 (30 Kit), 00815381020321 (6 Kit); Model Nos RFIT-ASY-0143 (30 Kit), RFIT-ASY-0142 (6 Kit); Lot Numbers 0638426, 0638526, 0676426, 0676526, 0679726, 0804826, 0804926, 0805026, 0883126, 0922126, 0941426, 0941526, 0997926, 0998026, 1020626, 1020726, 1077326, 1105326, 1118926, 1119026, 1119526, 1219226, 1239726, 1286526, 1286626, 1287326, 1287426, 1346226, 1346326, 1346426, 1403026, 1403126, 1403226, 1419326, 1419426, 1437626, 1479026, 1560626, 1560726, 1611826, 1611926, 1656926, 1683826, 1859726

View the original FDA recall notice

Why was this product recalled?

Due to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Biofire Diagnostics, LLC take?

On 09/03/2026, an "URGENT: MEDICAL DEVICE RECALL (CORRECTION)" Letter was emailed to customers informing them that, bioMrieux internally identified increased rates of KPC unexpected positives in Quality Control (QC) testing of the BIOFIRE FILMARRAY PN Panel, BIOFIRE FILMARRAY PNplus Panel, and BIOFIRE JI Panel. Internal testing reproduced KPC unexpected positive results, suggesting KPC nucleic acid contamination in reagent manufacturing at levels that can lead to false positive results. Customers are instructed to: " Examine inventory for the lots identified in this recall. " If a positive KPC result obtained when using the affected product is inconsistent with local resistance epidemiology and clinical data, then the result should be confirmed with an alternative method. " If customer has further distributed or transferred this product to another facility, identify any recipients, notify them at once, and forward this notice. " Post the recall (correction) letter on or near affected products as a constant reminder of the actions that need to be taken. " Complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification. For questions - contact your local Customer Service Representative at 1-800-682-2666, selecting option 1 for Technical Support and option 3 for BIOFIRE, or email [email protected]

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology